Spots Global Cancer Trial Database for pet
Every month we try and update this database with for pet cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| 18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study | NCT04995185 | Nasopharyngeal ... | (18)F-fluoromis... | 21 Years - 99 Years | National Cancer Centre, Singapore | |
| Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi | NCT05929222 | Follicular Lymp... | Radiotherapy Radiotherapy pl... | 18 Years - | Fondazione Italiana Linfomi - ETS | |
| GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancer | NCT01176513 | Prostate Cancer | GE-148 (18F) | 18 Years - | GE Healthcare | |
| Follow-up of Patients With Curative-Intent Surgical Resection for NSCLC | NCT00199615 | Non-Small Cell ... | PET | 18 Years - | University Hospital, Limoges | |
| Application of FAPI and FDG PET Imaging in Patients With Different Types of Cancer | NCT06284070 | Cancer | 18 Years - | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | ||
| Application of FAPI and FDG PET Imaging in Patients With Different Types of Cancer | NCT06284070 | Cancer | 18 Years - | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | ||
| Imaging of Solid Tumors Using FAP-2286 | NCT04621435 | Solid Tumors, A... Metastatic Canc... | Gallium-68 labe... Positron Emissi... Copper-64 label... | 18 Years - | University of California, San Francisco | |
| Natural History of Familial Carcinoid Tumor | NCT00646022 | Carcinoid | [18F]-DOPA | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma | NCT01898273 | Glioblastoma | I-124-CLR1404 | 18 Years - | Cellectar Biosciences, Inc. | |
| The Research on 89Zr-ABT806 PET Imaging in High Grade Glioma | NCT03058198 | Glioma | 89Zr-ABT806 PET | 18 Years - | Huashan Hospital | |
| Positron Emission Mammography (PEM) Biopsy Accessory for the Diagnosis of Breast Cancer | NCT00981812 | Breast Cancer | PEM Breast Biop... | 25 Years - | University of Cincinnati | |
| Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON) | NCT01690325 | Breast Cancer | Docetaxel Trastuzumab Bevacizumab Epirubicin Cyclophosphamid | 18 Years - 65 Years | West German Study Group | |
| Wholebody MRI In Lung Cancer StagiNg | NCT02716051 | Lung Cancer | MRI PET | 18 Years - | University Hospital, Limoges | |
| Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer. | NCT00620243 | Ovarian Cancer | 1: FDG PET | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer Patients | NCT03648151 | Lung Cancer Image, Body | - | The First Affiliated Hospital of Shanxi Medical University | ||
| Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment | NCT00324467 | Lymphoma, Non-H... Advanced Stage ... | Cyclophosphamid... Doxorubicin Vincristine Prednisone Ondansetron Dexamethasone Diphenhydramine Acetaminophen Ifosfamide Mesna (IV) Mesna (oral) Carboplatin Etoposide Rituximab Ondansetron Dexamethasone Diphenhydramine Acetaminophen PET Scan | 18 Years - | British Columbia Cancer Agency | |
| Positron Emission Tomography (PET) Interest in the Follow Up of Colorectal Cancer Stage II and III | NCT00199654 | Colorectal Canc... | PET | 18 Years - | University Hospital, Limoges | |
| Early Treatment Stratification Based on PET Scan Response to Chemotherapy in Patients With Diffuse Large B-cell Lymphoma | NCT01361191 | Diffuse Large B... Follicular Grad... | R-MEGACHOP | 18 Years - 65 Years | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | |
| Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma | NCT01028638 | Metastatic Rena... | 89Zr-bevacizuma... | 18 Years - | University Medical Center Groningen | |
| Choline PET/CT and MRI for Targeted Prostate Biopsy | NCT01751737 | Prostate Cancer | Prostate Cancer... | 40 Years - | University of Michigan | |
| Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6 | NCT06228482 | Metastatic Nons... | [68Ga]Ga DOTA-5... | 18 Years - | University of California, Davis | |
| Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer | NCT00165568 | Colorectal Canc... Neoplasm Metast... | Bevacizumab | 18 Years - | Dana-Farber Cancer Institute | |
| A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib | NCT00453362 | Non-Small Cell ... | 2-deoxy-2-[18F]... 3'-deoxy-3'-[18... erlotinib HCl | 18 Years - | Genentech, Inc. | |
| An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer | NCT01266954 | Solid Tumours | GSK2141795 | 18 Years - 85 Years | GlaxoSmithKline | |
| Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas | NCT06389123 | Metastatic Canc... | [68Ga]Ga DOTA-5... | 18 Years - | University of California, Davis | |
| Pilot Study of 18F Fluoropaclitaxel (FPAC) | NCT00572598 | Breast Cancer | 4- [F-18] fluor... | 18 Years - 90 Years | Virginia Commonwealth University | |
| PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer | NCT06074510 | Prostate Cancer | Piflufolastat F... | 18 Years - | Lantheus Medical Imaging | |
| FBnTP Imaging of Breast Cancer | NCT02204462 | Breast Cancer | FBnTP | 26 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Molecular Imaging of Fulvestrant Effects on Availability of ER Binding Sites | NCT01377324 | Metastatic Brea... | Diagnostic inte... | 18 Years - | University Medical Center Groningen | |
| Can Hybrid PET-MRI Differentiate Between Radiation Effects and Disease Progression? | NCT03068520 | Brain Tumor | PET MR | 18 Years - 70 Years | Assuta Medical Center | |
| FDG and FDOPA PET Demonstration of Functional Brain Abnormalities | NCT04315584 | Glioblastoma | Positron Emissi... Computed Tomogr... Multiparametric... Fludeoxyglucose... fluorine F 18 f... | 18 Years - | University of Virginia | |
| Molecular Imaging of Fulvestrant Effects on Availability of ER Binding Sites | NCT01377324 | Metastatic Brea... | Diagnostic inte... | 18 Years - | University Medical Center Groningen | |
| HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer | NCT03827317 | Breast Cancer | [18F]GE-226 | 18 Years - | Imperial College London | |
| Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer | NCT00199680 | Cervical Cancer | PET | 18 Years - | University Hospital, Limoges | |
| Functional Imaging in HNC Undergoing Chemoradiation | NCT00837980 | Head and Neck C... | 18 Years - | Royal Marsden NHS Foundation Trust | ||
| PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial) | NCT00201942 | Breast Cancer | PET scan | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis | NCT01433445 | Idiopathic Myel... Post Essential ... Post Polycythem... | panobinostat ruxolitinib | 18 Years - | Novartis | |
| Evaluation of Fapi-pet in Prostate Cancer. | NCT05192694 | Prostate Cancer | Computed tomogr... | 18 Years - 100 Years | Helsinki University Central Hospital | |
| Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL) | NCT00795613 | HODGKIN LYMPHOM... | ESCALATED BEACO... CONVENTIONAL AB... | 18 Years - 60 Years | Ospedale Santa Croce-Carle Cuneo | |
| Calibration of MR and PET-MR Imaging Protocols at RIC | NCT02249520 | Cancer Coronary Artery... | PET-MR imaging ... MR-only imaging... MR imaging on t... | 18 Years - | Cedars-Sinai Medical Center | |
| Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate Cancer | NCT00520546 | Prostate Cancer | 18F-Ethylcholin... Endorectal Magn... | 50 Years - | German Federal Armed Forces | |
| HD18 for Advanced Stages in Hodgkins Lymphoma | NCT00515554 | Hodgkins Lympho... | Rituximab BEACOPP escalat... | 18 Years - 60 Years | University of Cologne | |
| Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer | NCT00572728 | Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | CT 18F-FLT PET | 18 Years - | National Cancer Institute (NCI) | |
| The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases | NCT01180907 | Cancer Inflammation | 18 Years - | Jonsson Comprehensive Cancer Center | ||
| HD17 for Intermediate Stage Hodgkin Lymphoma | NCT01356680 | Hodgkin Lymphom... | BEACOPPescalate... ABVD (Adriamyci... 30Gy IF-RT (Inv... 30Gy IN-RT (Inv... | 18 Years - 60 Years | University of Cologne | |
| Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma | NCT02515084 | Thyroid Cancer Relapse | PET MRI imaging | 18 Years - | Centre Henri Becquerel | |
| Imaging of Solid Tumors Using FAP-2286 | NCT04621435 | Solid Tumors, A... Metastatic Canc... | Gallium-68 labe... Positron Emissi... Copper-64 label... | 18 Years - | University of California, San Francisco | |
| Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors | NCT00163176 | Head and Neck N... | 18 Years - | Radboud University Medical Center | ||
| GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancer | NCT01176513 | Prostate Cancer | GE-148 (18F) | 18 Years - | GE Healthcare | |
| 89Zr-KN035 PET Imaging in Patients With Advanced Solid Tumors | NCT03638804 | Solid Tumor, Ad... | 89Zr-KN035 | 18 Years - 75 Years | The First Affiliated Hospital of Soochow University | |
| A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma | NCT00498043 | Lymphoma, B-Cel... Lymphoma, Large... | R-CHOP14 induct... R-ACVBP14 induc... | 18 Years - 59 Years | Hospices Civils de Lyon | |
| Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence | NCT05856409 | 68Ga-FAPI Ovarian Cancer Epithelial Ovar... Positron Emissi... | 68Ga-FAPI | 18 Years - 80 Years | RenJi Hospital | |
| Evaluation de O-(2-[18F]-Fluoroethyl)-L-Tyrosine, a New Tracer PET, in the Diagnosis of Low Grade Glioma | NCT02286531 | Low Grade Gliom... | O-(2[18F]FLUORO... | 18 Years - | University Hospital, Toulouse | |
| Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid Tumors | NCT02345174 | Cancer Neoplasms | GSK2849330 89Zr-GSK2849330 | 18 Years - | GlaxoSmithKline | |
| Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL) | NCT00795613 | HODGKIN LYMPHOM... | ESCALATED BEACO... CONVENTIONAL AB... | 18 Years - 60 Years | Ospedale Santa Croce-Carle Cuneo | |
| Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma | NCT02515084 | Thyroid Cancer Relapse | PET MRI imaging | 18 Years - | Centre Henri Becquerel | |
| An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries | NCT02247713 | Non Small Cell ... | 18 Years - | The Netherlands Cancer Institute | ||
| Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma | NCT01028638 | Metastatic Rena... | 89Zr-bevacizuma... | 18 Years - | University Medical Center Groningen | |
| PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma | NCT03791905 | Neoplasm, Esoph... Squamous Cell C... | Paclitaxel Cisplatin Oxaliplatin 5-FU Leucovorin Intensity-modul... PET | 18 Years - 70 Years | Sun Yat-sen University | |
| PET-CT in Diagnosis of Pancreatic Cystic Neoplasms | NCT01317836 | Neoplasms Pancreatic Canc... | 18 Years - | Turku University Hospital | ||
| Sequential FDG-PET (Positron Emission Tomography) and Induction Chemotherapy in Locally Advanced Adenocarcinoma of the Esophagogastric Junction (AEG) | NCT01271322 | Adenocarcinomas... | neoadjuvant rad... | 18 Years - 75 Years | National Center for Tumor Diseases, Heidelberg | |
| Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular Lymphoma | NCT00915096 | Lymphoma, Folli... | 18 Years - 80 Years | Lymphoma Study Association | ||
| 131MIBG to Treat Malignant Pheochromocytoma | NCT00028106 | Pheochromocytom... | [131]I-MIBG 6-[18F]Fluorodo... [123]I-MIBG | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
| A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo | NCT02496832 | Pancreatic Aden... Advanced Diseas... Metastatic Dise... | 18F-Fluoroazomy... | 18 Years - | University Health Network, Toronto | |
| In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study | NCT01995084 | Pancreatic Canc... Esophageal Canc... Rectal Cancer | [F-18]HX4 | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Carbon-11 Labeled Sarcosine in Prostate Cancer | NCT02462447 | Prostate Cancer | 11C-sarcosine 11C-choline | 40 Years - | University of Michigan | |
| Follow-up of Patients With Curative-Intent Surgical Resection for NSCLC | NCT00199615 | Non-Small Cell ... | PET | 18 Years - | University Hospital, Limoges | |
| HD17 for Intermediate Stage Hodgkin Lymphoma | NCT01356680 | Hodgkin Lymphom... | BEACOPPescalate... ABVD (Adriamyci... 30Gy IF-RT (Inv... 30Gy IN-RT (Inv... | 18 Years - 60 Years | University of Cologne | |
| 99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate Cancer | NCT06219746 | Prostate Cancer | PSMA-imaging | 18 Years - | Turku University Hospital | |
| A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma | NCT00498043 | Lymphoma, B-Cel... Lymphoma, Large... | R-CHOP14 induct... R-ACVBP14 induc... | 18 Years - 59 Years | Hospices Civils de Lyon | |
| Early Chemotherapy Intensification in Interim-Positron Emission Tomography (PET) Positive Hodgkin Lymphoma | NCT00877747 | Hodgkin Lymphom... | 16 Years - 80 Years | Ospedale Santa Croce-Carle Cuneo | ||
| PET With [18F]HX4 in Head and Neck Cancer | NCT01347281 | Cancer of the H... | Injection of [1... | 18 Years - 100 Years | Maastricht Radiation Oncology | |
| 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia | NCT01916148 | Congenital Hype... Beckwith-Wiedem... Insulinoma | 18F-DOPA | - | Children's Hospital of Philadelphia | |
| HD17 for Intermediate Stage Hodgkin Lymphoma | NCT01356680 | Hodgkin Lymphom... | BEACOPPescalate... ABVD (Adriamyci... 30Gy IF-RT (Inv... 30Gy IN-RT (Inv... | 18 Years - 60 Years | University of Cologne | |
| Positron Emission Tomography in Patients With Breast Cancer | NCT00001385 | Breast Neoplasm... | - | National Institutes of Health Clinical Center (CC) | ||
| Ga68-DOTA-NOC-PET Imaging of Neuroendocrine Tumors | NCT00569738 | Neuroendocrine ... | PET scan with G... | 18 Years - | Hadassah Medical Organization | |
| CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma | NCT03427476 | Renal Cell Carc... | CTT1057 | 18 Years - | Cancer Targeted Technology | |
| An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries | NCT02247713 | Non Small Cell ... | 18 Years - | The Netherlands Cancer Institute | ||
| Natural History of Familial Carcinoid Tumor | NCT00646022 | Carcinoid | [18F]-DOPA | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| 89Zr-KN035 PET Imaging in Patients With Advanced Solid Tumors | NCT03638804 | Solid Tumor, Ad... | 89Zr-KN035 | 18 Years - 75 Years | The First Affiliated Hospital of Soochow University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
